Additionally, MDSCs can interact with tumor-associated B cells or regulatory B cell (Breg) cells through EVs, transmitting PD-L1 to regulate B cell function and consequently inhibiting the typical immune function of CD8+ T cells, thereby suppressing immune function in GBM [452]. The gene discussed is CD8A; the disease is glioblastoma.